Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Immunogenicity of One Single Administration of PCV-LITE, a Novel Adjuvanted Pneumococcal Conjugate Vaccine Supplemented With LiteVax Adjuvant, in Young Healthy Participants

NCT06986239 is registered in ClinicalTrials.gov with LiteVax BV as lead sponsor.

NCT NCT06986239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06986239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Immunogenicity of One Single Administration of PCV-LITE, a Novel Adjuvanted Pneumococcal Conjugate Vaccine Supplemented With LiteVax Adjuvant, in Young Healthy Participants
Lead sponsor
LiteVax BV
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2026
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vaccine reaction